[ad_1]
Aurogen South Africa (Aurogen), a wholly owned subsidiary of Aurobindo Pharma in South Africa, has entered into an agreement with Novabee Proprietary to sell and divest Aurogen’s entire 50% shareholding in Novagen. After the sale of 50% of the shares held by Aurogen, Aurogen will cease to be the joint venture partner of Novagen.
Powered by Capital Market – Live News
Click here to join us on WhatsApp
Disclaimer: No Business Standard journalists were involved in the creation of this content.
First publication: October 5, 2024 | 10:21 a.m. STI